News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CLX Medical, Inc. (CLXN) Announces Selection of Laboratory for Pre-Clinical Trials Validation Study on Zonda, Inc.'s Rapid Point of Care Test for Chlamydia



4/22/2008 10:10:22 AM

MURRIETA, CA--(Marketwire - April 22, 2008) - CLX Medical, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that the company has selected IIT Research Institute (IITRI) (http://www.iitri.org) to serve as the laboratory that will conduct a validation study for Zonda's rapid point of care test for chlamydia.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES